Blood Preparation Market Share, Growth & Forecast by 2034

Coverage: By Product Type (Whole Blood, Blood Components, and Blood Derivatives); Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others); End Use (Hospitals, Clinics, Diagnostic Centers, Research Labs, Blood Banks, Pharmaceuticals, and Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Historic Data: 2021-2024 | Base Year: 2025 | Forecast Period: 2026-2034
  • Status : Data Released
  • Report Code : TIPRE00023674
  • Category : Life Sciences
  • No. of Pages : 150
  • Available Report Formats : pdf-format excel-format
  • Last update date : May 26, 2026
Blood Preparation Market Share, Growth & Forecast by 2034
Report Date: May 26, 2026   |   Report Code: TIPRE00023674 Email: sales@theinsightpartners.com

2025 Market Size

US$ 53.63 Bn

Base year value

2034 Forecast

US$ 83.66 Bn

Projected by 2034

CAGR 2026-2034

5.72 %

Growth rate

Addressable Market

US$ 644.03 Bn

(2026-2034)

The Blood Preparation Market size is expected to reach US$ 83.66 Billion by 2034 from US$ 53.63 Billion in 2025. The market is estimated to record a CAGR of 5.72% from 2026 to 2034.

The report is segmented By Product Type (Whole Blood, Blood Components, and Blood Derivatives); Application (Thrombocytosis, Pulmonary Embolism, Renal Impairment, Angina Blood Vessel Complications, and Others); End Use (Hospitals, Clinics, Diagnostic Centers, Research Labs, Blood Banks, Pharmaceuticals, and Others),

The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Blood Preparation Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  1. Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  2. Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  3. Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Blood Preparation Market Segmentation Product Type

  1. Whole Blood
  2. Blood Components
  3. Blood Derivatives

Application

  1. Thrombocytosis
  2. Pulmonary Embolism
  3. Renal Impairment
  4. Angina Blood Vessel Complications
  5. Others

End Use

  1. Hospitals
  2. Clinics
  3. Diagnostic Centers
  4. Research Labs
  5. Blood Banks
  6. Pharmaceuticals
  7. Others

Geography

  1. North America
  2. Europe
  3. Asia-Pacific
  4. South and Central America
  5. Middle East and Africa

Market Assessment and Insights

  • Global market for Blood Preparation was valued at US$ 53.63 Billion in 2025
  • Annual market size is expected to reach US$ 83.66 Billion by 2034
  • Total addressable market (TAM) during 2026-2034 is projected to reach approximately US$ 644.03 Billion
  • Market is anticipated to register a CAGR of 5.72% during the forecast period
  • The United States represents a key market, supported by Growing Incidence of Blood Disorders, Technology in Blood Donation and Storage, Surge in Surgical Procedures and Trauma Cases, as well as evolving industry dynamics
  • Market analysis covers North America, Europe, Asia-Pacific, South and Central America, Middle East and Africa, with growth evaluated across the forecast period
  • Market opportunities such as Expansion into Emerging Markets, Development of Synthetic Blood Products, Strategic Partnership with Hospitals and Blood Banks are expected to influence market dynamics and addressable market
  • Report profiles industry participants, including AstraZeneca PLC, Sanofi S.A, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International, Inc, Pfizer, Inc., Portola Pharmaceuticals, Inc., GlaxoSmithKline PLC, Shandong East Chemical Industry Co, Celgene Corporation, while analyzing competitive strategies and innovation developments
  • Source: The Insight Partners' analysis based on proprietary research, government publications, company annual reports, investor presentations, industry databases, and expert interviews.

● REPORT CUSTOMIZATION

Tailor This Report To Align With Your Specific Business Requirements

This report can be customized to align precisely with your business objectives, scope, and target markets. Customization options include tailored segmentation, geography, competitive analysis, and strategic insights to support informed decision-making.

Customize This Report →

WHAT YOU CAN ADJUST

  • Segmentations
  • Geography
  • Competitive Analysis
  • Language Preferences

Blood Preparation Market: Strategic Insights

blood-preparation-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Blood Preparation Market Growth Drivers

  1. Growing Incidence of Blood Disorders: One of the major driving forces for blood preparation is growing incidence of blood disorders like anemia, hemophilia, and leukemia. Their repeated transfusions and therapies that include other blood components have increased the need for all types of blood preparations, ranging from whole blood, plasma, and red blood cell concentrates, throughout the world.
  2. Technology in Blood Donation and Storage: Safety and Efficiency Through Better Collection, Processing, and Storage of Blood The use of technology improves safety and efficiency in preparing blood with better collection, processing, and storage methods. Improved storage methods in the form of pathogen reduction and cryopreservation for blood products provide for a sustained supply chain to meet the fast-growing demand for transfusions.
  3. Surge in Surgical Procedures and Trauma Cases: The growth in surgical procedures, including organ transplants and cardiovascular surgeries and trauma care has increased the requirement of blood preparations. Blood preparations are required to be used as indispensable surgery in high volume transfusion requirements; however, their demand increases with the increasing number of accidents and emergencies, where immediate blood replacement is required

Blood Preparation Market Future Trends

  1. Advances in personalized blood therapy: There is an increasing tendency of personalization in blood transfusion medicine where the products used for transfusion are individualized toward the needs of each patient. Genetic markers, blood type compatibility, and treatment history are matched to enhance the rate of success in transfusion and reduce the complications arising from transfusion.
  2. Automated Blood Collection and Processing: The market is being redefined by automation in the process of blood collection and processing. Such advanced systems would surely pick up quickly where blood can be separated into its different components, and contaminants can be detected and hence more efficiency ensured. It would then reduce human error as well as improve the quality and safety of the preparations.
  3. Increase Plasma Derivative Products: Plasma derivative products, for example, immunoglobulins, clotting factors, and albumin are becoming increasingly used due to its extremely vital role in treating immune deficiency, bleeding disorders, as well as more serious diseases. A higher demand for these products puts pressure on the industry of blood preparation to expand more in plasma collection and processing for ever-changing medical needs

Blood Preparation Market Opportunities

  1. Expansion into Emerging Markets: The blood preparation market has immense growth potential in the emerging markets in Asia-Pacific and Africa. In these regions, infrastructural advancement in healthcare through urbanization and improved health care awareness are boosting the demand for blood transfusions, thus offering an excellent time to companies to expand their operations here.
  2. Development of Synthetic Blood Products: Synthetic blood products should be enough to overcome the shortage of donated blood, which is currently under research and development. Synthetic blood substitutes that imitate the oxygen-carrying function of natural blood may revolutionize the market by offering an alternative in emergencies, military use, and in regions where challenges in blood donations are involved.
  3. Strategic Partnership with Hospitals and Blood Banks: Companies will be offered a chance to ensure that blood preparations meet the standards of consistency, quality, and also reaching the patient. It can be implemented by entering into partnerships with health institutions in standardizing the collection, storage, and distribution process to enable patients to have immediate availability of the needful blood products

Blood Preparation Market Report Scope

Report Attribute Details
Market size in 2025 US$ 53.63 Billion
Market Size by 2034 US$ 83.66 Billion
Global CAGR (2026 - 2034) 5.72%
Historical Data 2021-2024
Forecast period 2026-2034
Segments Covered By Product Type
  • Whole Blood
  • Blood Components
  • Blood Derivatives
By Application
  • Thrombocytosis
  • Pulmonary Embolism
  • Renal Impairment
  • Angina Blood Vessel Complications
  • Others
By End Use
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Labs
  • Blood Banks
  • Pharmaceuticals
  • Others
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • AstraZeneca PLC
  • Sanofi S.A
  • LEO Pharma A/S
  • Bristol-Myers Squibb Company
  • Baxter International, Inc
  • Pfizer, Inc.
  • Portola Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC
  • Shandong East Chemical Industry Co
  • Celgene Corporation

Blood Preparation Market Players Density: Understanding Its Impact on Business Dynamics

The Blood Preparation Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

blood-preparation-market-cagr

Key Selling Points

  1. Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Blood Preparation Market, providing a holistic landscape.
  2. Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  3. Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  4. Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Blood Preparation Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


Frequently Asked Questions

AstraZeneca PLC ,Sanofi S.A ,LEO Pharma A/S ,Bristol-Myers Squibb Company ,Baxter International, Inc,Pfizer, Inc.

Asia Pacific is estimated to grow at the highest CAGR of 5.72% from 2026 to 2034

North America region accounts for highest revenue share Blood Preparation market

The final report will duly include market size and projection estimates for all the segments from 2021 to 2034, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2024 are the historic years, 2025 is considered to be the base year, and the forecast will be provided till 2034, along with CAGR of 5.72% from 2026 to 2034

AstraZeneca PLC Sanofi S.A LEO Pharma A/S Bristol-Myers Squibb Company Baxter International, Inc Pfizer, Inc. Portola Pharmaceuticals, Inc. GlaxoSmithKline PLC Shandong East Chemical Industry Co

The market is expected to grow at a CAGR of 5.72% from 2026 to 2034
Mrinal Kerhalkar
Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

  • Comprehensive Market Sizing and Forecast Analysis
  • Detailed Segmentation Analysis
  • In-Depth Market Dynamics Assessment
  • Regional and Country-Level Insights
  • Competitive Landscape and Company Benchmarking
  • Strategic Business Intelligence

Testimonials

Reason to Buy

  • Informed Decision-Making
  • Understanding Market Dynamics
  • Competitive Analysis
  • Identifying Emerging Markets
  • Customer Insights
  • Market Forecasts
  • Risk Mitigation
  • Boosting Operational Efficiency
  • Strategic Planning
  • Investment Justification
  • Tracking Industry Innovations
  • Aligning with Regulatory Trends
Sales Assistance
US: +1-646-491-9876
UK: +44-20-8125-4005
DUNS Logo
ISO Certified Logo
GDPR
CCPA